IBDEI0Y3 ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,15184,2)
 ;;=^5063401
 ;;^UTILITY(U,$J,358.3,15185,0)
 ;;=Z85.09^^85^842^6
 ;;^UTILITY(U,$J,358.3,15185,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15185,1,3,0)
 ;;=3^Personal Hx malignancy,Biliary tract & Gallbladder
 ;;^UTILITY(U,$J,358.3,15185,1,4,0)
 ;;=4^Z85.09
 ;;^UTILITY(U,$J,358.3,15185,2)
 ;;=^5063406
 ;;^UTILITY(U,$J,358.3,15186,0)
 ;;=Z85.05^^85^842^9
 ;;^UTILITY(U,$J,358.3,15186,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15186,1,3,0)
 ;;=3^Personal Hx malignancy,Liver
 ;;^UTILITY(U,$J,358.3,15186,1,4,0)
 ;;=4^Z85.05
 ;;^UTILITY(U,$J,358.3,15186,2)
 ;;=^5063402
 ;;^UTILITY(U,$J,358.3,15187,0)
 ;;=Z12.0^^85^842^15
 ;;^UTILITY(U,$J,358.3,15187,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15187,1,3,0)
 ;;=3^Screening for Gastric Cancer
 ;;^UTILITY(U,$J,358.3,15187,1,4,0)
 ;;=4^Z12.0
 ;;^UTILITY(U,$J,358.3,15187,2)
 ;;=^5062679
 ;;^UTILITY(U,$J,358.3,15188,0)
 ;;=Z13.811^^85^842^16
 ;;^UTILITY(U,$J,358.3,15188,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15188,1,3,0)
 ;;=3^Screening for Lower Gastrointestinal Disorder(s)
 ;;^UTILITY(U,$J,358.3,15188,1,4,0)
 ;;=4^Z13.811
 ;;^UTILITY(U,$J,358.3,15188,2)
 ;;=^5062711
 ;;^UTILITY(U,$J,358.3,15189,0)
 ;;=Z13.810^^85^842^17
 ;;^UTILITY(U,$J,358.3,15189,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15189,1,3,0)
 ;;=3^Screening for Upper Gastrointestinal Disorder(s)
 ;;^UTILITY(U,$J,358.3,15189,1,4,0)
 ;;=4^Z13.810
 ;;^UTILITY(U,$J,358.3,15189,2)
 ;;=^5062710
 ;;^UTILITY(U,$J,358.3,15190,0)
 ;;=Z11.0^^85^842^18
 ;;^UTILITY(U,$J,358.3,15190,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15190,1,3,0)
 ;;=3^Screening for Viral Intestinal Diseases
 ;;^UTILITY(U,$J,358.3,15190,1,4,0)
 ;;=4^Z11.0
 ;;^UTILITY(U,$J,358.3,15190,2)
 ;;=^5062669
 ;;^UTILITY(U,$J,358.3,15191,0)
 ;;=K82.4^^85^843^30
 ;;^UTILITY(U,$J,358.3,15191,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15191,1,3,0)
 ;;=3^Polyp of Gallbladder
 ;;^UTILITY(U,$J,358.3,15191,1,4,0)
 ;;=4^K82.4
 ;;^UTILITY(U,$J,358.3,15191,2)
 ;;=^265888
 ;;^UTILITY(U,$J,358.3,15192,0)
 ;;=C23.^^85^843^27
 ;;^UTILITY(U,$J,358.3,15192,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15192,1,3,0)
 ;;=3^Malignant neoplasm,Gallbladder
 ;;^UTILITY(U,$J,358.3,15192,1,4,0)
 ;;=4^C23.
 ;;^UTILITY(U,$J,358.3,15192,2)
 ;;=^267098
 ;;^UTILITY(U,$J,358.3,15193,0)
 ;;=K82.8^^85^843^21
 ;;^UTILITY(U,$J,358.3,15193,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15193,1,3,0)
 ;;=3^Gallbladder dyskinesia
 ;;^UTILITY(U,$J,358.3,15193,1,4,0)
 ;;=4^K82.8
 ;;^UTILITY(U,$J,358.3,15193,2)
 ;;=^5008874
 ;;^UTILITY(U,$J,358.3,15194,0)
 ;;=R17.^^85^843^24
 ;;^UTILITY(U,$J,358.3,15194,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15194,1,3,0)
 ;;=3^Jaundice
 ;;^UTILITY(U,$J,358.3,15194,1,4,0)
 ;;=4^R17.
 ;;^UTILITY(U,$J,358.3,15194,2)
 ;;=^5019251
 ;;^UTILITY(U,$J,358.3,15195,0)
 ;;=C24.0^^85^843^26
 ;;^UTILITY(U,$J,358.3,15195,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15195,1,3,0)
 ;;=3^Malignant neoplasm,Extrahepatic bile duct
 ;;^UTILITY(U,$J,358.3,15195,1,4,0)
 ;;=4^C24.0
 ;;^UTILITY(U,$J,358.3,15195,2)
 ;;=^5000940
 ;;^UTILITY(U,$J,358.3,15196,0)
 ;;=K83.9^^85^843^19
 ;;^UTILITY(U,$J,358.3,15196,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15196,1,3,0)
 ;;=3^Disease of Biliary tract,unspec
 ;;^UTILITY(U,$J,358.3,15196,1,4,0)
 ;;=4^K83.9
 ;;^UTILITY(U,$J,358.3,15196,2)
 ;;=^5008881
 ;;^UTILITY(U,$J,358.3,15197,0)
 ;;=K80.33^^85^843^4
